Search

everythinglearnresearchcommunity

for

Search:↓

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Menopause affects hair and skin; more research needed for treatment.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Young men's sexual dysfunction often has physical causes, which can lead to stress and worsen the problem.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

Finasteride treats hair loss but may cause low libido, erectile issues, and depression.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

A group has developed therapies that show promise for treating cancer and various other conditions.

High-intensity interval training (HIIT) is better than moderate-intensity continuous training (MICT) for improving health in overweight women with PCOS.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.